HUP0003393A3 - Ustained-release delayed gels - Google Patents

Ustained-release delayed gels

Info

Publication number
HUP0003393A3
HUP0003393A3 HU0003393A HUP0003393A HUP0003393A3 HU P0003393 A3 HUP0003393 A3 HU P0003393A3 HU 0003393 A HU0003393 A HU 0003393A HU P0003393 A HUP0003393 A HU P0003393A HU P0003393 A3 HUP0003393 A3 HU P0003393A3
Authority
HU
Hungary
Prior art keywords
ustained
release delayed
delayed gels
gels
release
Prior art date
Application number
HU0003393A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Amgen Inc Thousand Oaks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc Thousand Oaks filed Critical Amgen Inc Thousand Oaks
Publication of HUP0003393A2 publication Critical patent/HUP0003393A2/hu
Publication of HUP0003393A3 publication Critical patent/HUP0003393A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU0003393A 1997-05-16 1998-05-18 Ustained-release delayed gels HUP0003393A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85797397A 1997-05-16 1997-05-16
US91290297A 1997-08-15 1997-08-15

Publications (2)

Publication Number Publication Date
HUP0003393A2 HUP0003393A2 (hu) 2001-02-28
HUP0003393A3 true HUP0003393A3 (en) 2001-03-28

Family

ID=27127437

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003393A HUP0003393A3 (en) 1997-05-16 1998-05-18 Ustained-release delayed gels

Country Status (18)

Country Link
EP (1) EP0981374B1 (https=)
JP (1) JP2001525826A (https=)
KR (1) KR20010012374A (https=)
AU (1) AU7491898A (https=)
BG (1) BG64860B1 (https=)
BR (1) BR9809117A (https=)
CA (1) CA2289196C (https=)
CZ (1) CZ299180B6 (https=)
DE (1) DE69838750T2 (https=)
EA (1) EA199901013A1 (https=)
ES (1) ES2294814T3 (https=)
HU (1) HUP0003393A3 (https=)
IL (1) IL132814A0 (https=)
NO (1) NO995591L (https=)
PL (1) PL199565B1 (https=)
SK (1) SK286437B6 (https=)
WO (1) WO1998051348A2 (https=)
YU (1) YU58599A (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200609B2 (en) * 1998-05-18 2006-02-23 Amgen Inc. Biodegradable sustained-release alginate gels
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
JP2000256216A (ja) * 1999-03-04 2000-09-19 Meiji Milk Prod Co Ltd ゲル組成物
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
CA2396431A1 (en) * 1999-11-29 2001-05-31 Advanced Research And Technology Institute, Inc. Sustained percutaneous delivery of a biologically active substance
FR2823119B1 (fr) * 2001-04-05 2004-02-20 Seppic Sa Adjuvant d'immunite contenant un cation metallique complexe et vaccin le contenant
JP2006505579A (ja) * 2002-10-25 2006-02-16 ファイザー・プロダクツ・インク 懸濁形態でのアリール複素環活性薬物の蓄積製剤
JP5336180B2 (ja) * 2005-05-23 2013-11-06 ナチュラル オータナティブス インターナショナル β−アラニンの徐放のための組成物及び方法
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
JP5107585B2 (ja) * 2007-01-29 2012-12-26 株式会社 メドレックス 低温充填ゼリー組成物とその製造方法
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
US20120271272A1 (en) 2010-10-15 2012-10-25 Iscience Interventional Corporation Device for ocular access
EP2916827B1 (en) 2012-11-08 2020-06-10 Clearside Biomedical Inc. Methods for the treatment of ocular disease in human subjects
SG10201702674PA (en) 2013-05-03 2017-06-29 Clearside Biomedical Inc Apparatus and methods for ocular injection
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
RU2710491C2 (ru) 2014-06-20 2019-12-26 Клиасайд Байомедикал, Инк. Устройство для инъекции лекарственного средства в глазную ткань и способ инъекции лекарственного средства в глазную ткань
WO2017139375A1 (en) 2016-02-10 2017-08-17 Clearside Biomedical, Inc. Ocular injection kit, packaging, and methods of use
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
EP3496680B1 (en) 2016-08-12 2024-10-02 Clearside Biomedical, Inc. Device for adjusting the insertion depth of a needle for medicament delivery
WO2018204515A1 (en) 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
AU2019282111C1 (en) * 2018-06-04 2022-08-11 Spermvital As Functionalized kit for preparing hydrogels
EP3878476B1 (en) * 2018-11-06 2025-10-01 National Cancer Center Alginic acid-based injectable hydrogel system
JP2022550457A (ja) * 2019-10-01 2022-12-01 ブリリアン・ファーマ・インコーポレイテッド 肥満の処置又は防止及び体重管理の方法
EP4130235A4 (en) * 2020-03-26 2024-07-10 Osaka University SUPPORT BATH FOR THREE-DIMENSIONAL (3D) TISSUE CULTURE
CN114533653B (zh) * 2020-11-26 2023-12-22 上海凯茂生物医药有限公司 一种人促红素杂合Fc融合蛋白相变型制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5416979B2 (https=) * 1972-01-08 1979-06-26
US4241099A (en) * 1979-02-26 1980-12-23 Tiemstra Peter J Pectin formulations, products and methods having delayed-action acidulants
US4690682A (en) * 1983-04-15 1987-09-01 Damon Biotech, Inc. Sustained release
US4789516A (en) * 1983-04-15 1988-12-06 Damon Biotech, Inc Production of sustained released system
US4744933A (en) * 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
JPS645460A (en) * 1987-06-29 1989-01-10 Sanei Kagaku Kogyo Kk Production of delaying gelatinous material
JPH0794583B2 (ja) * 1989-12-15 1995-10-11 株式会社大塚製薬工場 高含水高分子ゲル
IT1245383B (it) * 1991-03-28 1994-09-20 Eniricerche Spa Composizione acquosa gelificabile avente tempo di gelificazione ritardato
US5711968A (en) * 1994-07-25 1998-01-27 Alkermes Controlled Therapeutics, Inc. Composition and method for the controlled release of metal cation-stabilized interferon
KR960006730B1 (ko) * 1993-02-11 1996-05-23 재단법인한국화학연구소 에멀젼 네트웍(emulsion network)을 이용한 약물의 피부 전달체계
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions

Also Published As

Publication number Publication date
JP2001525826A (ja) 2001-12-11
IL132814A0 (en) 2001-03-19
CZ396399A3 (cs) 2000-04-12
ES2294814T3 (es) 2008-04-01
EP0981374A2 (en) 2000-03-01
HUP0003393A2 (hu) 2001-02-28
WO1998051348A2 (en) 1998-11-19
PL199565B1 (pl) 2008-10-31
KR20010012374A (ko) 2001-02-15
EA199901013A1 (ru) 2000-06-26
CZ299180B6 (cs) 2008-05-14
PL336887A1 (en) 2000-07-17
BG64860B1 (bg) 2006-07-31
BR9809117A (pt) 2000-08-01
YU58599A (sh) 2000-12-28
SK286437B6 (sk) 2008-10-07
NO995591D0 (no) 1999-11-15
DE69838750T2 (de) 2008-10-30
WO1998051348A3 (en) 1999-02-18
BG103914A (en) 2000-07-31
CA2289196A1 (en) 1998-11-19
DE69838750D1 (de) 2008-01-03
AU7491898A (en) 1998-12-08
EP0981374B1 (en) 2007-11-21
CA2289196C (en) 2007-08-07
NO995591L (no) 1999-11-15
SK154399A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
HUP0003393A3 (en) Ustained-release delayed gels
AU134327S (en) Reflector
DE59803915D1 (en) Bandwaage
DE59805100D1 (en) Containerbrücke
DE59803341D1 (en) Handhobelmaschine
DE59808840D1 (en) Compoundpumpe
DE69727985D1 (en) Extravasationserkennungsvorrichtung
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
DE59811907D1 (en) Transponder-system
DE59708342D1 (en) Basophilen-degranulationstest
DE69729893D1 (en) Druckbläter
DE69715258D1 (en) Präzisionshydraulikfutter
GB9704709D0 (en) Gels
DE59806884D1 (en) Dexamethason-gel
DE69737400D1 (en) Substituierte naphthopyrane
GB9712000D0 (en) Premeable reflector
GB9721046D0 (en) Fragriroll
DE69735266D1 (en) Substituierte naphthopyrane
DE59811113D1 (en) Laryngoskop
CA82218S (en) Sports-glasses
CA82746S (en) Handleset
CA79884S (en) Moniitor
CA80851S (en) Thermomter
DE59809032D1 (en) Telephonsystem
CA82748S (en) Handleset

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees